Pharmacokinetics and Antibody Responses to the CD3 Antibody Otelixizumab Used in the Treatment of Type 1 Diabetes
Hale, Geoff, Rebello, Peppy, Al Bakir, Ibrahim, Bolam, Emma, Wiczling, Pawel, Jusko, William J., Vandemeulebroucke, Evy, Keymeulen, Bart, Mathieu, Chantal, Ziegler, Annette-G, Chatenoud, Lucienne, WalVolume:
50
Language:
english
Journal:
The Journal of Clinical Pharmacology
DOI:
10.1177/0091270009356299
Date:
November, 2010
File:
PDF, 750 KB
english, 2010